drugset / Trial / NCT02054936

Evaluation of Wound Drainage After Knee or Hip Arthroplasty

NCT02054936

Phase 4 Withdrawn University of Michigan
RandomizedParallel-groupSingle-blindTreatment

Summary

To compare side effects and complications relating to use of warfarin or rivaroxaban, tolerance and/or toxicity of these two agents such as drop in hemoglobin post operatively, extent of bruising, quantity of wound drainage, duration of drainage, wound swelling, sub and supra-therapeutic prothrombin times, need for transfusion, and patient tolerance in two randomized groups. Return visits to the operating room, length of stay, and VTE rates will also be compared.

Timeline

Start
2014-03
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rivaroxaban Other / unclassified 10 mg
Comparator Warfarin Small molecule

Indications

No indication recorded.